• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOVENTUS LLC SUPARTZ FX PFS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOVENTUS LLC SUPARTZ FX PFS Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Headache (1880); Itching Sensation (1943); Reaction (2414)
Event Date 07/20/2018
Event Type  Injury  
Event Description
Pt stated he spoke to another rep (b)(6) 2018 and informed them of immediate allergic reaction once med was administered: itching at inj site, stiff neck, "major headache" all started at 8:20am.Per pt, md switching him to gelsyn-3 instead.Dose or amount: 25mg, frequency: weekly, route: intra articularly to.Dates of use: from (b)(6) 2018.Diagnosis or reason for use: bilateral primary osteoarthritis of knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPARTZ FX PFS
Type of Device
SUPARTZ FX PFS
Manufacturer (Section D)
BIOVENTUS LLC
MDR Report Key7757506
MDR Text Key116372190
Report NumberMW5078910
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 07/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/06/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age62 YR
-
-